Literature DB >> 32044410

Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.

Rachel G Casseres1, Lisa Prussick1, Pedro Zancanaro2, Brooke Rothstein2, Deep Joshipura2, Ami Saraiya2, Yana Turkowski2, Shiu Chung Au2, Abdulaziz Alomran2, Rana Abdat2, Minawaer Abudu2, Courtney Kachuk2, Nicole Dumont2, Alice B Gottlieb3, David Rosmarin4.   

Abstract

Entities:  

Year:  2020        PMID： 32044410     DOI： 10.1016/j.jaad.2020.02.005

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  12 in total

Review 1.  Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.

Authors:  Chun-Hsien Huang; I-Hsin Huang; Cheng-Chen Tai; Ching-Chi Chi
Journal:  Biomedicines       Date:  2022-06-02

2.  Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.

Authors:  Kristina Navrazhina; John W Frew; David Grand; Samuel C Williams; Hong Hur; Juana Gonzalez; Sandra Garcet; James G Krueger
Journal:  Br J Dermatol       Date:  2022-06-02       Impact factor: 11.113

3.  Primary imputation methods impact efficacy results in hidradenitis suppurativa clinical trials.

Authors:  John W Frew
Journal:  J Am Acad Dermatol       Date:  2020-04-02       Impact factor: 11.527

Review 4.  IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa.

Authors:  J M Fletcher; B Moran; A Petrasca; C M Smith
Journal:  Clin Exp Immunol       Date:  2020-06-08       Impact factor: 4.330

Review 5.  Skin manifestations in spondyloarthritis.

Authors:  Katharina Meier; Alexandra Schloegl; Denis Poddubnyy; Kamran Ghoreschi
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-12-08       Impact factor: 5.346

Review 6.  Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil.

Authors:  Maria Cecilia Rivitti-Machado; Renata Ferreira Magalhães; Roberto Souto da Silva; Gleison V Duarte; Fabiana Zs Bosnich; Roberto Gaspar Tunala; Francisco José Forestiero
Journal:  Drugs Context       Date:  2022-01-19

7.  The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.

Authors:  Kristina Navrazhina; Sandra Garcet; John W Frew; Xiuzhong Zheng; Israel Coats; Emma Guttman-Yassky; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2021-07-30       Impact factor: 11.527

8.  Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report.

Authors:  Pelin Esme; Gulsen Akoglu; Ercan Caliskan
Journal:  Skin Appendage Disord       Date:  2020-12-09

Review 9.  [Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update].

Authors:  P Cramer; S Schneider-Burrus; M Kovács; L Scholl; M Podda; F G Bechara
Journal:  Hautarzt       Date:  2021-07-06       Impact factor: 0.751

10.  COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.

Authors:  Andrea Chiricozzi; Simone Garcovich; Dalma Malvaso; Giulia Giovanardi; Ketty Peris
Journal:  Int J Dermatol       Date:  2020-09-23       Impact factor: 3.204
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.